The present invention relates to a transgenic mouse whose genome is heterozygous for a disruption of a native Elovl4 gene. The transgenic mouse and cells derived therefrom can be used to screen drug or food supplement for the treatment and prevention of visual disorders such as Stargardt-like dominant macular dystrophy.

 
Web www.patentalert.com

< Rotary cutter assembly

< Method for preparing emulsions

> Process of manufacturing and using highly refined fiber mass

> Shirred casing

~ 00222